HAE.NYSEHaemonetics CORP

Form 4: Haemonetics Corp Executive Roy Galvin Reports Stock Transaction

Sentiment:

SEC Form 4 Filing

📋All filings for Haemonetics CORP
🔒Login to Follow

Roy Galvin, President, Global Plasma & BC at Haemonetics Corp, reports disposition of shares to cover tax obligations and acquisition of shares through an employee stock purchase plan.

Summary

  • On May 15, 2024, Roy Galvin, President, Global Plasma & BC of Haemonetics Corp, reported a transaction involving the company's common stock.
  • 214 shares were disposed of to cover tax obligations related to the vesting of restricted stock units at a price of $96.49 per share.
  • Following the transaction, Galvin directly owns 4,538 shares, which includes unvested RSUs and 157 shares acquired through the company's Employee Stock Purchase Plan on April 30, 2024.

Sentiment

Score: 6

Explanation: The sentiment is neutral as the filing represents a routine transaction for tax purposes and participation in an employee stock purchase plan.

Positives

  • Galvin's participation in the Employee Stock Purchase Plan indicates confidence in the company's future.

Industry Context

Form 4 filings are standard disclosures required by the SEC when company insiders, like officers and directors, trade their company's stock. These filings provide transparency to the market regarding insider activity.

Stakeholder Impact

  • The transaction has a minimal impact on stakeholders as it is a routine sale of shares for tax purposes.

Key Dates

DateDescription
April 30, 2024Reporting person acquired 157 shares under the Issuer's 2007 Employee Stock Purchase Plan (as amended).
May 15, 2024Roy Galvin disposed of 214 shares to cover tax obligations related to vesting of restricted stock units.
May 17, 2024Date of signature for the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.